Skip to main content
Schedule a call
March 21, 2022

Creating Access to Appropriate Therapeutic Pharmacy Alternatives

Wednesday April 27th, 11-12 EST

Generics are Coming to Market for HIV and Humira. How does an Employer Ensure they Maximize this Opportunity?
In the next few years there are some big drugs that will have biosimilar or generic alternatives that are complete therapeutic alternatives coming to market, but employers may not appreciate their impact on their finances due to market influencers.

During this session, you will learn:

  • What market influencers exist that will impact your ability to get these meds on your formulary
  • How the brand manufacturers and PBMs position things to make the impact of the alternative medications less impactful
  • Understand options to take control and secure your plan members access to the medications they deserve
  • Establish PBM contracts that don’t create barriers to your own success

    • Speakers:

  • Brenda Motheral, CEO of Archimedes
  • Barbara Brungess, Principal of Arevema
  • Alex Oshmyansky- CEO, Cost Plus Drugs

    • See what acting on your data looks like

    Have a conversation with our team to learn how we differ from the healthcare data analytics companies you’ve worked with before.
    Schedule a call